跳至主要内容
临床试验/NCT02053090
NCT02053090已完成不适用

Complementary and Alternative Medicine (CAM) for Fibromyalgia

Oregon Health and Science University2 个研究点 分布在 1 个国家目标入组 431 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
431
试验地点
2
主要终点
Treatment Participation Rate

研究概览

简要总结

This study is an acceptability and feasibility study of two adjunctive interventions: group education with stretching; and group acupuncture. The study population will be women with primary fibromyalgia who have not previously used acupuncture in the last 3 months. Both interventions will be 10 weeks in length and will be conducted at the Oregon Health & Science University. The primary hypothesis is that both arms will be acceptable and feasible in the study population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Having met American College of Rheumatology (1990) criteria for the diagnosis of fibromyalgia
  • Having a primary Traditional Chinese Medicine (TCM) diagnosis of either Liver Qi Stagnation, Qi and Blood Stagnation, or Qi and Blood Deficiency
  • Female gender
  • Reported average pain of 5 or higher over last week on a scale of 0 to 10 with ten indicating higher pain.
  • Willingness to limit the introduction or change of any medications or treatment modalities for control of fibromyalgia symptoms during the study
  • No TCM in last 3 months (including acupuncture, Chinese herbs or herbal tea pills, tuina (Chinese massage), shiatsu (Japanese massage), qigong and Oriental food therapy)
  • Ability to travel to the intervention and testing sites up to two times weekly
  • Being over 18 and under 75 years of age, and
  • Capability of giving informed consent.

排除标准

  • Presence of a known coagulation abnormality, thrombocytopenia, or bleeding diathesis that may preclude the safe use of acupuncture;
  • Individuals with celiac disease
  • A score greater than 29 on the Beck Depression Inventory
  • Presence of concurrent autoimmune disease such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, that causes pain and could potentially confound the analysis;
  • Routine daily use of narcotic analgesics or history of substance abuse;
  • Concurrent participation in other therapeutic trials;
  • Pregnant and nursing mothers (verification of pregnancy status will be determined via a urine test);
  • Severe psychiatric illnesses (current schizophrenia, major depression with suicidal ideation, substance abuse within two years);
  • Are undergoing disability determination, or are involved in litigation related to fibromyalgia
  • Any impairment, activity or situation that in the judgment of the PI would prevent satisfactory completion of the study protocol
  • Cognitive behavioral therapy in the last 6 months.
  • Non-fluency in English

结局指标

主要结局

Treatment Participation Rate

时间窗: 10 weeks

Rates of treatment attendance in both arms

次要结局

  • Fibromyalgia Impact Questionnaire Revised(Weeks 0, 5, 10, and 14)
  • Completion of Evaluation Rates(Weeks 0, 5, 10 and 14)
  • Drop out rate(10 and 14 weeks)
  • Nociceptive Reflex Testing(Weeks 0, 5, 10 and 14)
  • Sleep Quality and Daily Activity(Weeks 0, 5, 10, and 14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Mist

Assistant Professor

Oregon Health and Science University

研究点 (2)

Loading locations...

相似试验

Complementary and Alternative Medicine (CAM) for... | 临床试验